192 related articles for article (PubMed ID: 6283175)
21. Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide.
Graham D; Larder BA; Inglis MM
J Gen Virol; 1986 Apr; 67 ( Pt 4)():753-8. PubMed ID: 3007662
[TBL] [Abstract][Full Text] [Related]
22. Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity.
Liu QY; Summers WC
Virology; 1988 Apr; 163(2):638-42. PubMed ID: 2833027
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses.
Chatis PA; Crumpacker CS
Virology; 1991 Feb; 180(2):793-7. PubMed ID: 1846499
[TBL] [Abstract][Full Text] [Related]
24. Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.
Pan D; Coen DM
J Virol; 2012 Apr; 86(8):4518-26. PubMed ID: 22301158
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
O'Brien WJ; Taylor JL
Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase.
Larsson A; Tao PZ
Antimicrob Agents Chemother; 1984 Apr; 25(4):524-6. PubMed ID: 6329085
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
28. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
29. Alterations in the recognition of nucleoside analogues as substrates by the deoxythymidine kinase of a 5-methoxymethyldeoxyuridine-resistant mutant of herpes simplex virus type 1.
Veerisetty V; Veerisetty IK; Gentry GA
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2767-70. PubMed ID: 6319559
[TBL] [Abstract][Full Text] [Related]
30. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
Honess RW; O'Hare P; Young D
J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
[TBL] [Abstract][Full Text] [Related]
31. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
Veerisetty V; Gentry GA
Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
[No Abstract] [Full Text] [Related]
32. Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity.
Mendel DB; Barkhimer DB; Chen MS
Antimicrob Agents Chemother; 1995 Sep; 39(9):2120-2. PubMed ID: 8540727
[TBL] [Abstract][Full Text] [Related]
33. Preliminary characterization of a mutant of herpes simplex virus type 1 selected for acycloguanosine resistance in vitro.
Palú G; Summers WP; Valisena S; Tognon M
J Med Virol; 1988 Mar; 24(3):251-62. PubMed ID: 2835423
[TBL] [Abstract][Full Text] [Related]
34. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
Harmenberg J; Källander CF; Gronowitz JS
Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the role of the cysteine 171 residue in the activity of herpes simplex virus type 1 thymidine kinase by oligonucleotide-directed mutagenesis.
Inglis MM; Darby G
J Gen Virol; 1987 Jan; 68 ( Pt 1)():39-46. PubMed ID: 3027247
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
37. Significance of resistance of herpes simplex virus to acyclovir.
Crumpacker CS
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):190-5. PubMed ID: 2828441
[TBL] [Abstract][Full Text] [Related]
38. [Cloning, expression, isolation and properties of thymidine kinase herpes simplex virus, strain L2].
Stepanenko VN; Esipov R; Miroshnikov AI; Andronova VL; Galegov GA; Ias'ko MV; Gus'kova AV; Skoblov AIu; Skoblov IuS
Bioorg Khim; 2011; 37(4):490-5. PubMed ID: 22096991
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.
Tanaka S; Toh Y; Mori R
Arch Virol; 1993; 131(1-2):61-73. PubMed ID: 8392322
[TBL] [Abstract][Full Text] [Related]
40. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
